Fig. 2From: The efficacy and safety of methylprednisolone in hepatitis B virus-related acute-on-chronic liver failure: a prospective multi-center clinical triala A significant survival advantage was observed during 6 months among patients who received methylprednisolone. b The mortality during different time. c The causes-of-death in different groupsBack to article page
